Recent news on Nascobal

Nastech Announces First Quarter 2007 Financial Results  -  May 7, 2007
PR-Inside.com (Pressemitteilung),...in Nascobal(R) product sales. The prior year period included recognition of approximately $3.7 million in previously deferred revenue from Merck & Co.,

Exubera has opened door for pulmonary delivery growth  -  Apr 16, 2007
OutSourcing-Pharma.com,NS (butorphanol), marketed by Bristol-Myers Squibb for acute migraine pain, and Nascobal (cyanocobalamin, QOL Medical) for vitamin B12 deficiency.

Nastech Announces Fourth Quarter and Full Year 2006 Financial Results  -  27 Mar 2007
Drug Newswire (press release),We also had approximately $0.7 million in product revenue related to sales of our Nascobal(R) gel and spray products. Our net loss for the three months

Nastech Announces Third Quarter 2006 Financial Results  Nov 2, 2006
...milestone payment received and recognized in June 2006, revenue from our other collaborative agreements and approximately $0.6 million in Nascobal(R) product ... -Drug Newswire (press release), Questcor Announces Financial Results for 2006 Third Quarter  Nov 2, 2006
Questcor’s results for the three and nine months ended September 30, 2006 included the sale of Questcor’s non-core products Nascobal ® , Ethamolin ® and ... -Business Wire (press release), Nastech Announces Third Quarter 2006 Financial Results  Nov 1, 2006
...payment received and recognized in June 2006, revenue from our other collaborative agreements and approximately $0.6 million in Nascobal® product sales. ... -Yahoo! News (press release) Nastech Announces Second Quarter 2006 Financial Results  Aug 2, 2006
...milestone payment received and recognized in June 2006, revenue from our other collaborative agreements and approximately $0.6 million in Nascobal(R) product ... -PharmaLive.com

Nastech Announces Second Quarter 2006 Financial Results  Aug 2, 2006
...payment received and recognized in June 2006, revenue from our other collaborative agreements and approximately $0.6 million in Nascobal® product sales. ... -Yahoo! News

Questcor Announces Financial Results for 2006 Second Quarter ...  Aug 8, 2006
These changes primarily included the sale of Questcor's non-coreproducts Nascobal(R), Ethamolin(R) and Glofil(R)-125 and theretirement of Questcor's ... -Finanzen.net

Questcor Announces Financial Results for 2006 Second Quarter ...  Aug 8, 2006
These changes primarily included the sale of Questcor's non-core products Nascobal(R), Ethamolin(R) and Glofil(R)-125 and the retirement of Questcor's ... -Business Wire

Clinication Develops Website for Nascobal Drug Spray Users  Jul 10, 2006
...a software firm focused on developing means to improving patient compliance, has developed a website for users of a drug spray developed by Nascobal. ... -Local Tech Wire



Questcor Announces Financial Results for the First Quarter of 2006 ...  May 9, 2006
...the net product sales of Acthar Gel.Total net product sales for the first quarter of 2005 included the netproduct sales of Acthar Gel, Nascobal(R), Ethamolin(R ... - Finanzen.net

Questcor Announces Financial Results for the First Quarter of 2006 ...  May 9, 2006
Total net product sales for the first quarter of 2005 included the net product sales of Acthar Gel, Nascobal(R), Ethamolin(R), Glofil(R)-125, and VSL#3(R). As ... - PharmaLive.com

Nastech Announces First Quarter 2006 Financial Results  May 3, 2006
...("P&G"), revenue from our four other collaborative agreements and approximately $0.4 million in Nascobal(R) product sales. The prior ... - PharmaLive.com





Moving right along  Apr 10, 2006
150 Founded: 1983 Stock: NSTK on the Nasdaq market Web site: www.nastech.com Products Nastech has one FDA-approved product on the market, Nascobal, a vitamin ... - The Herald

Nastech Announces Fourth Quarter and Full Year 2005 Financial ...  Mar 16, 2006
Additionally, we received and recognized a $2 million milestone in the first quarter of 2005 from the FDA approval of Nascobal(R) spray. ... - PharmaLive.com

Questcor Announces Financial Results for 2005 and the Expansion of ...  Mar 9, 2006
...its strategy to focus on the development and commercialization of CNS products, on October 17, 2005 Questcor completed the sale of its Nascobal(R), Ethamolin(R ... - PharmaLive.com

Nastech Announces Fourth Quarter and Full Year 2005 Financial ...  Mar 15, 2006
Additionally, we received and recognized a $2 million milestone in the first quarter of 2005 from the FDA approval of Nascobal® spray. ... - Yahoo! News

This site is for informational purposes only--it does not offer medical advice or sell health products. If you need assistance, contact your physician or healthcare professional